Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Singewald

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Neuroscience and Biobehavioral Reviews|April 20, 2006
Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mappingNicolas Singewald
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 20, 2007
Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline releaseKarl Ebner, Nicolas Singewald
Neuropharmacology|January 16, 2003
Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatmentPeter Salchner, Nicolas Singewald
Psychopharmacology|March 8, 2006
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in ratsPeter Salchner, Nicolas Singewald
Psychopharmacology|November 1, 2018
Rodent models of impaired fear extinctionNicolas Singewald, Andrew Holmes
Trends in Neurosciences|December 25, 2012
Individual differences in recovery from traumatic fearAndrew Holmes, Nicolas Singewald
Biochemical Society Transactions|March 21, 2014
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?Nigel Whittle, Nicolas Singewald
Pharmacology & Therapeutics|February 21, 2025
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targetsAnupam Sah, Nicolas Singewald
Pharmacology & Therapeutics|August 31, 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disordersSimone B Sartori, Nicolas Singewald
Current Topics in Behavioral Neurosciences|September 6, 2019
Role of MicroRNAs in Anxiety and Anxiety-Related DisordersConor P Murphy, Nicolas Singewald
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Neuroscience and Biobehavioral Reviews|April 20, 2006
Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mappingNicolas Singewald
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 20, 2007
Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline releaseKarl Ebner, Nicolas Singewald
Neuropharmacology|January 16, 2003
Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatmentPeter Salchner, Nicolas Singewald
Psychopharmacology|March 8, 2006
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in ratsPeter Salchner, Nicolas Singewald
Psychopharmacology|November 1, 2018
Rodent models of impaired fear extinctionNicolas Singewald, Andrew Holmes
Trends in Neurosciences|December 25, 2012
Individual differences in recovery from traumatic fearAndrew Holmes, Nicolas Singewald
Biochemical Society Transactions|March 21, 2014
HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?Nigel Whittle, Nicolas Singewald
Pharmacology & Therapeutics|February 21, 2025
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targetsAnupam Sah, Nicolas Singewald
Pharmacology & Therapeutics|August 31, 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disordersSimone B Sartori, Nicolas Singewald
Current Topics in Behavioral Neurosciences|September 6, 2019
Role of MicroRNAs in Anxiety and Anxiety-Related DisordersConor P Murphy, Nicolas Singewald
Pageof 13